We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.49B
1-Year Est. Return 30.44%
This Fund
S&P 500
This Quarter Est. Return
+19.19%
1 Year Est. Return
+30.44%
3 Year Est. Return
+88.58%
5 Year Est. Return
+121.05%
10 Year Est. Return
+327.07%
AUM
$894M
AUM Growth
+$130M
Cap. Flow
-$279K
Cap. Flow %
-0.03%
Top 10 Hldgs %
39.67%
Holding
361
New
93
Increased
43
Reduced
107
Closed
58

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$20.9M
2
GRA
W.R. Grace & Co.
GRA
+$18.6M
3
AES icon
AES
AES
+$11.2M
4
PRMW
Primo Water Corporation
PRMW
+$8.57M
5
MRK icon
Merck
MRK
+$8.05M

Sector Composition

Rank Sector Weight
1 Financials 19.86%
2 Technology 17.34%
3 Consumer Discretionary 12.77%
4 Healthcare 10.63%
5 Consumer Staples 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORLY icon
126
O'Reilly Automotive
ORLY
$74.9B
$625K 0.07%
20,730
QLYS icon
127
CALL
Qualys
QLYS
$6.51B
$609K 0.07%
+5,000
New +$495K
OC icon
128
Owens Corning
OC
$12.6B
$606K 0.07%
8,000
+2,000
+33% +$146K
RTX icon
129
RTX Corp
RTX
$302B
$606K 0.07%
8,476
PARA
130
DELISTED
Paramount Global Class B
PARA
$605K 0.07%
16,233
-208,962
-93% -$6.7M
LIN icon
131
Linde
LIN
$226B
$604K 0.07%
2,291
+800
+54% +$196K
MDLA
132
DELISTED
Medallia, Inc.
MDLA
$598K 0.07%
+18,000
New +$574K
GS icon
133
Goldman Sachs
GS
$301B
$590K 0.07%
2,237
-3,000
-57% -$668K
HESM icon
134
Hess Midstream
HESM
$5.2B
$587K 0.07%
+30,000
New +$543K
VG
135
DELISTED
Vonage Holdings Corporation
VG
$579K 0.06%
45,000
-99,000
-69% -$1.21M
CL icon
136
Colgate-Palmolive
CL
$73.6B
$551K 0.06%
6,445
PFPT
137
DELISTED
Proofpoint, Inc.
PFPT
$546K 0.06%
4,000
-2,000
-33% -$219K
PFPT
138
PUT
DELISTED
Proofpoint, Inc.
PFPT
$546K 0.06%
+4,000
New +$438K
NPTN
139
DELISTED
NEOPHOTONICS CORP
NPTN
$545K 0.06%
+60,000
New +$464K
EPD icon
140
Enterprise Products Partners
EPD
$81.8B
$542K 0.06%
27,655
+2,570
+10% +$47.9K
GLNG icon
141
CALL
Golar LNG
GLNG
$5.17B
$530K 0.06%
+55,000
New +$478K
CIEN icon
142
Ciena
CIEN
$54.9B
$529K 0.06%
+10,000
New +$444K
MD icon
143
PUT
Pediatrix Medical
MD
$2.12B
$528K 0.06%
+21,500
New +$404K
WT icon
144
WisdomTree
WT
$3.33B
$522K 0.06%
97,500
PCPC.U
145
DELISTED
Periphas Capital Partnering Corporation CAPS, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
PCPC.U
$522K 0.06%
+20,000
New +$513K
GLW icon
146
Corning
GLW
$137B
$516K 0.06%
14,321
-11,493
-45% -$408K
EMR icon
147
Emerson Electric
EMR
$91.7B
$512K 0.06%
6,374
QCOM icon
148
Qualcomm
QCOM
$171B
$503K 0.06%
3,300
-5,000
-60% -$696K
NPTN
149
CALL
DELISTED
NEOPHOTONICS CORP
NPTN
$500K 0.06%
+55,000
New +$425K
FNF icon
150
Fidelity National Financial
FNF
$12.8B
$497K 0.06%
13,224

Similar funds

Levin Capital Strategies's Q4 2020 Portfolio in Review

As of Q4 2020, Levin Capital Strategies held 361 positions worth $894M, up 17% from $764M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Levin Capital Strategies's Q4 2020 filing shows 93 new, 43 increased, 107 reduced and 58 closed positions. Its largest new stake was AES: 537,515 shares worth $12.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $15.8M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Levin Capital Strategies's largest Q4 2020 buy was AES: 537,515 shares worth $12.6M.
  • Levin Capital Strategies added most to Citigroup in Q4 2020, an estimated $20.9M increase.
  • Levin Capital Strategies's biggest Q4 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $15.8M.
  • Levin Capital Strategies fully exited iShares Russell 2000 ETF in Q4 2020, selling an estimated $14.5M.
  • Levin Capital Strategies's ten largest holdings make up 40% of its $894M portfolio in Q4 2020.
  • Levin Capital Strategies opened 93 new positions and closed 58 in Q4 2020.
  • Levin Capital Strategies's portfolio value rose 17% quarter-over-quarter to $894M.

Based on Levin Capital Strategies's 13F filing for Q4 2020, filed 16 Feb 2021.